Chia‐Lang Hsu

2.8k citations
118 papers · 1.8k indexed · h-index 25
Topics
Cancer Immunotherapy and Biomarkers (18 papers)Immune Cell Function and Interaction (13 papers)Cancer-related molecular mechanisms research (12 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Chia‐Lang Hsu

109 papers receiving 1.8k citations

Peers

Chia‐Lang Hsu
Comparison fields: 5 of 111
  • Molecular Biology 1.1k
  • Cancer Research 480
  • Immunology 387
  • Oncology 364
  • Pulmonary and Respiratory Medicine 312
Replace Han Yang with:
Han Yang China
Ludovica Ciuffreda Italy
Honyin Chiu United States
Jin‐Ku Lee South Korea
Takuya Nagata Japan
Shanshan Bai China
Sizhi Paul Gao United States
Xiaoxi Lv China
Jinyang Li United States
Hang‐zi Chen China
Chia‐Lang Hsu relative to Han Yang China Han Yang's profile →
Citations per field
00.5×
Han Yang · 1×
Citations per year

Countries citing papers authored by Chia‐Lang Hsu

Since Specialization
Citations

This map shows the geographic impact of Chia‐Lang Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Lang Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Lang Hsu more than expected).

Fields of papers citing papers by Chia‐Lang Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Lang Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Lang Hsu. The network helps show where Chia‐Lang Hsu may publish in the future.

Co-authorship network of co-authors of Chia‐Lang Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Lang Hsu. A scholar is included among the top collaborators of Chia‐Lang Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Lang Hsu. Chia‐Lang Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 18
3 0
4 0
5 2
6 3
7 14
8 12
9 6
10 1
11 17
12 12
13 9
14 9
15 0
16 2
17 1
18 3
19 13
20 42

About Chia‐Lang Hsu

Chia‐Lang Hsu is a scholar working on Cancer Research, Immunology and Hematology, having authored 118 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immune Cell Function and Interaction (13 papers) and Cancer-related molecular mechanisms research (12 papers). The work is most often cited by research in Cancer Research (480 citations), Immunology (387 citations) and Molecular Biology (1.1k citations). Chia‐Lang Hsu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Hsueh‐Fen Juan, Hsuan‐Cheng Huang, Da‐Liang Ou, Ann‐Lii Cheng, Chiun Hsu, Min‐Chuan Huang, Ueng‐Cheng Yang, Mei‐Chun Lin, Wen‐Ming Hsu and Li‐Ling Lin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026